The survival of HER2 positive screen detected breast cancers in the abscence of chemotherapy and herceptin.

被引：0
|
作者：
Johnson, R. L. [1 ]
Prasad, R. [1 ]
Knox, W. F. [1 ]
Byrne, G. [1 ]
Morris, J. [1 ]
Cramer, A. [1 ]
Wilson, A. [1 ]
Bundred, N. J. [1 ]
机构：
[1] Univ S Manchester Hosp, Manchester M20 8LR, Lancs, England
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S110 / S111
页数：2
相关论文
共 50 条
  • [1] HER2 Positive Breast Cancers with Progression
    Solanki, Malvika
    Chitambar, Christopher
    Jorns, Julie
    LABORATORY INVESTIGATION, 2019, 99
  • [2] HER2 Positive Breast Cancers with Progression
    Solanki, Malvika
    Chitambar, Christopher
    Jorns, Julie
    MODERN PATHOLOGY, 2019, 32
  • [3] Successful quality assurance program for HER2 testing in the NSABP trial for Herceptin.
    Paik, S
    Tan-Chiu, E
    Bryant, J
    Romond, E
    Brown, A
    Mull, J
    Hiller, W
    Finnigan, M
    Wolmark, N
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S31 - S31
  • [4] Predictors of Response to Trastuzumab Containing Neoadjuvant Chemotherapy in HER2 Positive Breast Cancers
    Li, X.
    Kanbour-Shakir, A.
    Dabbs, D.
    Bhargava, R.
    LABORATORY INVESTIGATION, 2012, 92 : 49A - 50A
  • [5] Predictors of Response to Trastuzumab Containing Neoadjuvant Chemotherapy in HER2 Positive Breast Cancers
    Li, X.
    Kanbour-Shakir, A.
    Dabbs, D.
    Bhargava, R.
    MODERN PATHOLOGY, 2012, 25 : 49A - 50A
  • [6] ER Positive Screen Detected Breast Cancers (SDBC) Do Not Require Chemotherapy
    Bundred, N. J.
    Morris, J.
    Cheung, S.
    Knox, W. F.
    Lawrence, G.
    CANCER RESEARCH, 2010, 70
  • [7] ER POSITIVE SCREEN DETECTED BREAST CANCERS (SDBC) DO NOT REQUIRE CHEMOTHERAPY
    Bundred, N. J.
    Morris, J.
    Cheung, S.
    Knox, W. F.
    Lawrence, G. M.
    EJC SUPPLEMENTS, 2010, 8 (06): : 9 - 10
  • [8] Delayed chemotherapy in HER2 positive breast cancer
    Hur, Ho
    Le, Amy
    Chang, Helena R.
    CANCER RESEARCH, 2020, 80 (04)
  • [9] Adjuvant chemotherapy of breast cancers with overexpression or HER2 amplification
    Petit, Thierry
    ONCOLOGIE, 2008, 10 : S64 - S67
  • [10] Experiences in drug discovery and development of anti-erbB2 (HER2) monoclonal antibody; Herceptin.
    Nihira, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 63P - 63P
12345